Treatments

Rates of long-term major adverse cardiovascular events (CVEs) fell after the COVID-19 pandemic began in early 2020 and remained lower over the next year among commercially insured New England patients seeking care, and the incidence of congestive heart failure (CHF) and angina (chest pain) remained lower than expected.

Country / Region Tags:

Global

United States

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Paxlovid Cuts Covid Death Risk. But Useage is Low --studies

Fri, 2024-01-05 10:22 — mike kraft

As Covid rises again, killing about 1,500 Americans each week, medical researchers are trying to understand why so few people are taking Paxlovid, a medicine that is stunningly effective in preventing severe illness and death from the disease.

ALSO SEE: Less than a third of high-risk COVID outpatients prescribed antivirals, study finds

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Paxlovid Cuts Covid Death Risk. But Useage is Low --studies
1 comment
Log in or register to post comments

Hydroxychloroquine, touted by then President Trump, could have caused 17,000 deaths during Covid -- study

Fri, 2024-01-05 09:58 — mike kraft

Hydroxychloroquine could have caused 17,000 deaths during Covid, study finds Former US President Donald Trump said: ‘What do you have to lose? Take it.’ POLITICO

Nearly 17,000 people may have died after taking hydroxycholoroquine during the first wave of Covid-19, according to a study by French researchers.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Opinion: COVID-19 has tested us. Will we be ready for the next pandemic?

Tue, 2024-01-02 18:02 — mike kraft

COVID-19 has tested us. Will we be ready for the next pandemic? An infectious disease expert with insider access gives his take on what we did well, what we need to fix, and how to prepare for future outbreaks. Science

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Opinion: COVID-19 has tested us. Will we be ready for the next pandemic?
Log in or register to post comments

Long covid still confounds us. Here’s what is now known.

Tue, 2024-01-02 10:40 — mike kraft

Four years on, long covid still confounds us. Here’s what we now know. As many as 7 percent of Americans report having suffered from a slew of lingering symptoms after enduring covid. Frances Stead Sellers The Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Long covid still confounds us. Here’s what is now known.
Log in or register to post comments

Drugmakers set to raise U.S. prices on at least 500 drugs in January--analysis

Fri, 2023-12-29 10:48 — mike kraft

Exclusive: Drugmakers set to raise U.S. prices on at least 500 drugs in January Drugmakers including Pfizer , Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January. Michael Erman,Patrick Wingrove Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Drugmakers set to raise U.S. prices on at least 500 drugs in January--analysis
Log in or register to post comments

Use of Covid antiviral medicineby infected Americans remains low --study

Thu, 2023-12-28 18:10 — mike kraft

COVID antiviral uptake low among eligible Americans Over the course of the study, most participants were eligible for antiviral use. CIDRAP

A new report published in Open Forum Infectious Diseases demonstrates that, despite the proven effectiveness of Paxlovid and molnupiravir against severe COVID-19 outcomes, uptake of these two antivirals remains low among Americans with COVID.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Use of Covid antiviral medicineby infected Americans remains low --study
Log in or register to post comments

No consistent link found between antiviral drugs like Paxlovid and COVID rebound --U.S.G. reviews

Fri, 2023-12-22 10:34 — mike kraft

Reviews uncover no consistent link between antiviral drugs like Paxlovid and COVID rebound Igor Vershinsky / iStock CIDRAP

Two systematic reviews by US federal agencies on the possible link between antiviral treatment for COVID-19 and viral rebound—one specifically on Paxlovid—find no consistent association. The studies were published yesteray in Morbidity and Mortality Weekly Report.

...

Country / Region Tags:

General Topic Tags: